Xihua Lian

Dr. Xihua Lian


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
XLXihua Lian
Xihua Lian
ASAmy Scott-Thomas
Amy Scott-Thomas
JLJohn G Lewis
John G Lewis
Madhav BhatiaMadhav Bhatia
Madhav Bhatia
SCStephen Thomas Chambers
Stephen Thomas Chambers
Due to the high morbidity and mortality rates of invasive aspergillosis (IA) and the importance of early IA detection for successful treatment and subsequent outcome, this study aimed to determine a time course of detectable antigen in a mouse model of IA and correlate it with tissue invasion by using two novel monoclonal antibodies, 1D2 and 4E4, that can be used to detect the Aspergillus-derived glycoproteins. Immunocompromised mice were randomly divided into five groups: uninfected control, and inoculation with conidia from Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger, and Aspergillus terreus. Conidia (2 × 106 cells/mL) were administered intravenously via tail vein injection. Three mice from each group were euthanised at each time point (6 h, 12 h, 18 h, 24 h, and 48 h) after inoculation. Urine and blood were collected for analysis using a double-sandwich ELISA using 1D2 and 4E4. Liver, spleen, and kidney tissues were harvested for tissue staining. The levels of liver injury in the IA mice progressively increased with time after inoculation with Aspergillus conidia. Following inoculation with A. fumigatus, swollen conidia were identified in the spleen, as well as antigens in blood after 18 h. Hyphae were detected in the spleen, liver, and kidney after 48 h. For A. flavus, the antibodies detected hyphae in the liver and spleen as well as circulating antigens in blood samples 48 h after inoculation. Tissue injury was observed in the mice inoculated with A. terreus and A. niger, but there was no evidence of fungal invasion or antigens in the blood. Antigens were not detectable in mouse urine but could be detected in glomeruli of the kidney by immunofluorescence. In conclusion, the mAb-based antigen detection double-sandwich ELISA results were consistent with the IHC results in this study. Novel monoclonal antibodies 1D2 and 4E4 can serve as tools for the early identification of IA in mice infected by A. fumigatus and A. flavus. This study also suggests the potential usefulness of this approach in human disease.

9 October 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SLSanhua Lian
Sanhua Lian
CSChunping Shi
Chunping Shi
FCFengyu Chen
Fengyu Chen
ZZZhixing Zhu
Zhixing Zhu
XLXihua Lian
Xihua Lian
Objective: To investigate the effects of social support and psychological interventions on COPD patients across varying severity levels.Methods: This prospective, randomized controlled study included 172 COPD patients from two hospitals between January 2021 and June 2024. Finally, 132 participants were enrolled and randomly assigned to an intervention group (n = 66), receiving standard medical treatment plus systematic social and psychological support, or a control group (n = 66), receiving standard treatment and routine health education. The intervention lasted for 12 months. Primary outcomes, including quality of life (SGRQ), mental health (HADS), exercise capacity (6MWT), dyspnea (MRC scale), and pulmonary function (FEV1, FVC, FEV1/FVC), were assessed before and after the intervention.Results: No significant baseline differences were observed. After 12 months, the intervention group showed significant improvements in SGRQ, HADS, and MRC scores (p < 0.05), 6MWT distance, and pulmonary function (p < 0.05). Mild and moderate COPD patients in the intervention group showed significant improvements in all outcomes compared to baseline and the control group (p < 0.05). Severe and very severe patients showed improvements in SGRQ and HADS scores (p < 0.05), but no changes in 6MWT or pulmonary function (p > 0.05).Conclusion: Structured social and psychological interventions significantly improve quality of life, mental health, exercise capacity, and pulmonary function in mild to moderate COPD patients, but with limited effects on severe and very severe patients.

30 June 2026 in Respiratory Medicine
Verified
Journal Article
Closed access
JYJiaohong Yang
Jiaohong Yang
YLYishan Lin
Yishan Lin
JBJing Bai
Jing Bai
ZZZhixing Zhu
Zhixing Zhu
XLXihua Lian
Xihua Lian

8 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
XLXihua Lian
Xihua Lian
SLShunlan Liu
Shunlan Liu
JBJing Bai
Jing Bai
YZYing Zhang
Ying Zhang
JYJiaohong Yang
Jiaohong Yang
ZZZhixing Zhu
Zhixing Zhu
Objectives: To develop and validate a transthoracic lung ultrasound (TLUS)-integrated clinical nomogram for predicting pulmonary arterial hypertension (PAH) in patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). Methods: This multicenter retrospective study included 550 patients with CTD-ILD from the Second Affiliated Hospital of Fujian Medical University and 169 external cases from the Xijing Hospital, Fourth Military Medical University. Patients were randomly divided into a training cohort (n = 385) and an internal validation cohort (n = 165); the external dataset served as a testing cohort. Demographic, physiological, laboratory, pulmonary function, and TLUS data were collected. Univariate and multivariate logistic regression analyses identified independent predictors of PAH, which were used to construct a nomogram model. Discrimination was assessed using receiver operating characteristic (ROC) curves and area under the curve (AUC) values. Calibration, decision curve analysis (DCA), and clinical impact curves (CIC) were performed to evaluate model accuracy and clinical utility. Results: Five independent predictors were identified: respiratory rate, diffusing capacity of the lung for carbon monoxide (DLCO% predicted), TLUS score, red blood cell (RBC) count, and brain natriuretic peptide (BNP). The model achieved excellent discrimination with AUCs of 0.952 (95% confidence interval [CI]: 0.927–0.977) in the training cohort, 0.935 (95% CI: 0.885–0.985) in the validation cohort, and 0.874 (95% CI: 0.806–0.942) in the testing cohort, outperforming individual predictors. Calibration plots showed close agreement between predicted and observed probabilities, while DCA and CIC confirmed strong clinical benefit and applicability across all thresholds. Conclusions: This TLUS-integrated nomogram provides a noninvasive and reliable tool for individualized PAH risk assessment in CTD-ILD patients. By combining ultrasound findings with physiological and laboratory markers, the model enables accurate detection of high-risk cases and may assist clinicians in optimizing surveillance and management strategies.

16 July 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
XLXihua Lian
Xihua Lian
ASAmy Scott-Thomas
Amy Scott-Thomas
JLJohn G Lewis
John G Lewis
Madhav BhatiaMadhav Bhatia
Madhav Bhatia
SCStephen Thomas Chambers
Stephen Thomas Chambers
Objective: To determine the in vitro anti-Aspergillus activity of monoclonal antibodies (mAb) 1D2 and 4E4 alone and in combination with voriconazole, posaconazole, amphotericin B and caspofungin and to assess whether selected antimicrobial agents interfere with 1D2/4E4 binding to Aspergillus antigens. Methods: The in vitro antifungal activity of 1D2, 4E4 and all antifungal drugs was determined in a microplate-based assay. The anti-Aspergillus activity of mAb 1D2 and 4E4 in vitro alone and in combination with voriconazole, posaconazole, amphotericin B and caspofungin was determined using a checkerboard assay. Finally, a competitive ELISA was used to assess whether selected antifungal and antibacterial agents interfered with the binding of 1D2 and 4E4 to immobilised Aspergillus antigens. Results: The in vitro interactions of 1D2 with voriconazole, posaconazole, amphotericin B and caspofungin against four different Aspergillus species were all additive, with a fractional inhibitory concentration index (FICI) between 0.5 and 1. Similarly, the in vitro interactions of 4E4 with these same four antifungals against Aspergillus fumigatus (A. fumigatus) were all additive. An additive interaction was also detected for 4E4 and caspofungin against all four Aspergillus species tested. However, no interaction was found for 4E4 combined with voriconazole, posaconazole and amphotericin B against Aspergillus flavus (A. flavus), Aspergillus niger (A. niger) and Aspergillus terreus (A. terreus), with an FICI between 1 and 4. Moreover, none of the tested antifungal or antibacterial agents significantly interfered with 1D2/4E4 binding to Aspergillus antigens in the competitive ELISA. Conclusions: In this study, 1D2 and 4E4 showed in vitro growth-inhibitory activity against the tested Aspergillus isolates. Specifically, 1D2 showed additive interactions with the tested antifungal agents across all tested species, whereas 4E4 showed a more species- and drug-dependent interaction profile. The tested antimicrobial agents did not measurably interfere with 1D2/4E4 binding under the competitive ELISA conditions examined. Overall, these findings provide preliminary in vitro evidence supporting the further evaluation of 1D2 and 4E4.

6 November 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
XLXihua Lian
Xihua Lian
SCStephen Thomas Chambers
Stephen Thomas Chambers
MMMiller Miller
Miller Miller
MDMatthew Drake
Matthew Drake
JLJohn G Lewis
John G Lewis
ASAmy Scott-Thomas
Amy Scott-Thomas
Objective: To investigate the prophylactic efficacy of monoclonal antibody (mAb) 1D2 against Aspergillus fumigatus in an immunosuppressed mouse model of invasive aspergillosis (IA). Methods: BALB/c mice (n = 18) were immunosuppressed with cyclophosphamide and randomly assigned into three groups (n = 6 each): 1D2 prophylaxis, isotype antibody (6B10) control and PBS control. Two hours prior to intravenous inoculation of A. fumigatus conidia (2 × 105 conidia per mouse), 1D2 (100 μg) or control interventions were administered intravenously. Clinical signs and body weight were monitored, and mice were euthanised for tissue and blood collection 48 h after infection. Liver injury was assessed histologically using a modified semi-quantitative scoring system. Fungal burden was assessed by colony-forming unit (CFU) counts in blood and sampled liver, spleen, kidney, and lung tissues. Plasma cytokine concentrations were analysed by ELISA. Results: 1D2-treated mice showed a lower loss of body weight post-inoculation than PBS controls (p = 0.007) and had significantly reduced clinical distress scores on days 1 and 2 (p < 0.05). Histopathological analysis showed alleviated liver injury in the 1D2 group, with a median liver injury score of 4.5 (IQR 3.0–5.25) versus 8.0 (IQR 6.75–10.0) in PBS controls (p < 0.05). CFU counts in the liver, spleen and kidney were significantly lower in the 1D2-treated group than in either control group (p < 0.05). Plasma IL-6 levels were reduced in the 1D2-treated group (582.9 ± 279.7 pg/mL) compared with PBS (1073 ± 289.1 pg/mL) and 6B10 (1080 ± 357.4 pg/mL)-treated controls (p < 0.05). TNF-α and IL-1 showed no significant differences. Conclusions: Prophylactic administration of mAb 1D2 was associated with reduced post-inoculation weight loss, lower clinical distress scores, less liver injury, and reduced recoverable CFU counts in sampled liver, spleen and kidney tissues. Plasma IL-6 concentrations were also lower in the 1D2-treated group. These findings provide proof-of-concept evidence supporting further preclinical evaluation of 1D2 as a prophylactic candidate against IA.